drugset / Trial / NCT01062750

Liver Regeneration Therapy by Intrahepatic Arterial Administration of Autologous Adipose Tissue Derived Stromal Cells

NCT01062750 ↗

Completed 4 enrolled Kanazawa University
NaSingle-groupOpen-labelTreatment

Summary

Mesenchymal stem cells have capability to differentiate into hepatocyte and will be useful for liver regeneration. Adipose tissue is relatively enriched with mesenchymal stem cell compared to bone marrow tissue. In this trial, eligible liver cirrhosis patients will receive autologous adipose tissue derived stromal cells through intrahepatic arterial catheterization.

Timeline

Start
2012-10
Primary completion
2015-02
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject adipose tissue derived stromal cells Cell therapy — Other

Indications